uMETHOD Health

01/01/2024

Happy New Year from our team here at uMETHOD! Our New Year's resolution is to have another great year of solidifying our commitment to creating customized care plans for physicians to treat their patients who have Alzheimer's and dementia.

12/26/2023

Merry Christmas and Happy Holidays to everyone this year! We look forward to this new year and all of the lives we can change with

12/01/2023

Announcement for Clinicians! Earn up to 22 CME credits to learn the latest technologies, diagnostics, and innovative treatments for dementia.
Collaborating with Quest Diagnostics and The Physician Transformation Institute, this is an opportunity to revolutionize the way we approach dementia care over 2 days.
Gain valuable insights on workflow optimization, billing, and coding as well as collaborative medicine and the Medicare Guide model.
Proceeds go toward designing anonymous mental health services for physicians and other healthcare professionals suffering from burnout.

Join healthcare professionals at the cutting-edge Demystifying Dementia Program in Houston, TX. Explore new test such as the Amyloid 42/40 test from Quest Diagnostics, game-changing AI tools, and Group Visit modalities for memory care & dementia management. 22 AMA PRA Category 1 CME.

11/21/2023

This Being Patient article offers details as to why doctors are missing cases of Mild Cognitive Impairment (MCI). This can be avoided by taking Dr. Sabbagh's advice; "If you feel something is going on, “don’t let doctors dismiss your concerns,” There are many underlying reasons you might be feeling off, and there may well be steps you can take to treat and even reverse these issues."
https://bit.ly/47pvJRB

A RestoreU care plan can help unlock the answers to what causes may be contributing to MCI and help stop its progression to dementia or Alzheimer's disease. Visit Restoreu.com for more.

Are doctors able to spot the signs of cognitive impairment in their older patients? According to two new research studies, doctors miss the majority...

11/16/2023

Did you know we use 30 years of Alzheimer’s research to formulate our RestoreU care plans? Watch this video of our CTO, John Q Walker, Ph. D to understand how exactly that works with customizing a patient’s care plan for doctors to be able to present to their patients and give reassurance to caregivers about the future of their loved ones.

11/11/2023

Honoring our veterans on this special Veterans Day! 🎖️ At uMETHOD, we stand in our commitment to and preserve veterans' health. Our blog post sheds light on the challenges veterans face and the innovative solutions provided by RestoreU. Let's come together to support our veterans and ensure they for a brighter future. 🙌🇺🇸
Read more here: https://umethod.com/veteransday/

11/03/2023

Let's unite to bring attention to a disease impacting millions in the US. Join us in raising awareness and supporting the fight against Alzheimer's! 💙 💜 Share our post to spread the word and discover the impact of Alzheimer's in our communities.
https://alzheimersnewstoday.com/news/supporters-shine-spotlight-disease-affecting-millions-us/

A range of events will be held in the U.S. in November to mark National Alzheimer's Awareness Month, and National Family Caregivers Month.

11/02/2023

uMETHOD Health Supports Alzheimer's Awareness Month! 🧠💙

We are thrilled to announce that uMETHOD Health, is taking a stance in raising awareness about Alzheimer's disease during Alzheimer's Awareness Month.

Alzheimer's disease affects millions of individuals worldwide, causing not only memory loss but also significant emotional and financial burdens for patients and their loved ones. As part of our commitment to making a difference, uMETHOD Health is dedicated to educating the public about the various factors that contribute to cognitive decline and the importance of early intervention.

During this Alzheimer's Awareness Month, we aim to shed light on the risk factors associated with Alzheimer's and emphasize the significance of early detection and personalized treatment plans. By understanding the underlying causes of cognitive decline, we can offer tailored solutions to individuals based on their unique circumstances.

Some of the factors that can contribute to cognitive decline include the presence of the APOE4 gene, co-existing conditions like thyroid and cardiovascular diseases, insulin resistance, vitamin D deficiency, and the impact of certain medications on chronic conditions.

At uMETHOD Health, we believe in the power of precision medicine and personalized care. Our approach combines advanced technology, genomic testing, and expert medical guidance to develop individualized treatment strategies for patients. By identifying and addressing the specific contributors to cognitive decline, we can potentially slow down the progression of Alzheimer's and enhance the quality of life for those affected.

Join us this Alzheimer's Awareness Month in spreading the word and raising awareness about this devastating disease. Together, we can make a difference by promoting early intervention, supporting ongoing research, and providing hope to individuals and families affected by Alzheimer's.

To learn more about uMETHOD Health's initiatives and how you can get involved, visit our website and read the full press release: [Insert URL]

Let's unite in the fight against Alzheimer's and work towards a future free from this debilitating disease. Together, we can make a lasting impact! 💙🌍

/PRNewswire/ -- uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, is taking an active role in drawing...

10/18/2023

📣 Exciting news from the ! Our founder, John Walker, represents uMETHOD, sharing groundbreaking insights on personalized healthcare. Be sure to watch him live at https://www.usa2summit.org/
Here are the key highlights he will hit on at 2:30pm EST.

uMETHOD Health creates personalized care plans for doctors, answering the crucial question: "Just Tell Me What to Do Now." These plans are based on 30 years of research and studies, translating complex data into actionable guidance for doctors, patients, and families.

By taking a comprehensive approach, uMETHOD Health intercepts cognitive decline at any stage: prevention, early symptoms, or progression. Doctors order a uMETHOD panel during lab tests, collecting over 100 biomarkers. Raw data, along with medical history, is analyzed by uMETHOD's software engine to generate care plans in simplified language for patients.

Multimorbidity and polypharmacy are common challenges. 80% of individuals have three or more chronic diseases. uMETHOD considers these conditions in its calculations, recognizing that cognitive issues are intertwined with overall health.

The engine also assesses medications. On average, patients take ten drugs, often causing brain fog or increasing the risk of falling. uMETHOD quantifies the cognitive impact of each drug and suggests alternatives. It identifies medications that exacerbate existing chronic conditions, like nephrotoxic drugs affecting kidney disease.

uMETHOD's care plans include the latest drug insights, such as Leqembi, and are fully reimbursed by Medicare. Over 10,000 individuals have benefited from uMETHOD's personalized approach.

Stay tuned for more updates as uMETHOD Health continues to redefine healthcare, making personalized medicine accessible to all. Together, let's create a cognitive blueprint🌐

10/05/2023

Visit our booth at the PriMed Conference to meet our talented team members, Staccey, Frank, and Martina! They will be there today and tomorrow to connect with over 165,000+ active primary care clinicians. Learn how our company is revolutionizing personal care plans for patients in the dementia and Alzheimer's space. Don't miss out!

09/25/2023

Join us in celebrating a significant milestone! We're thrilled to have received our first Care Plan for a patient with mild cognitive impairment at North Atlanta Primary Care. Special thanks to Dr. Murray and DeAndra McDuffie for their dedication and the utilization of cutting-edge technology from Quest Diagnostics and uMETHOD Health, Inc. patented technology.

09/22/2023

Did you attend the event?

We had the incredible opportunity to engage and connect with providers, discussing care pathways that can truly make a difference in improving patient outcomes. 🏥

One of the highlights was our discussion on the CMS guide, which presents a unique opportunity to enhance the quality of care for individuals living with dementia and Alzheimer's. By leveraging these guidelines, we can ensure that every patient receives the highest standard of care and support.

Together, let's continue to collaborate, innovate, and drive positive change in healthcare. By working hand in hand with providers, we can make a lasting impact on the lives of those affected by dementia and their families. 🤝